549 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

ALX Oncology Funding History

Since ALX Oncology was founded in 2015, it has participated in 7 rounds of funding. In total ALX Oncology has raised $706.6M. ALX Oncology's last funding round was on Oct 2023 for a total of $63.2M.

ALX Oncology Funding Rounds

Unlock 4 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Oct 2023
$63.2M
__
Post-IPO Debt
Oct 2022
$100M
2
Oxford Finance LLC,  Silicon Valley Bank
Post-IPO Equity
Dec 2020
$208M
__
IPO
Jul 2020
$169.4M
1
Series C
Feb 2020
$105M
8
Vivo Capital,  Logos Capital,  Janus Henderson,  Foresite Capital,  BVF Partners,  HBM Healthcare Investments,  venBio,  Lightstone Ventures

Total Funding: $706.6M

ALX Oncology Investors

Unlock 9 more investors →

INVESTOR

ROUND

FUNDING DATE

Oxford Finance LLC
Post-IPO Debt
Oct 2022
Silicon Valley Bank
Post-IPO Debt
Oct 2022
Vivo Capital
Series C
Feb 2020
Logos Capital
Series C
Feb 2020
Janus Henderson
Series C
Feb 2020

Total Investors: 12

ALX Oncology has 12 investors, including Oxford Finance LLC, Silicon Valley Bank and Vivo Capital. The latest investment occurred in Oct 2023.